ISPOR - Cost Analysis in Implementing Rituximab for non-Hodgkins Lymphoma - Intravenously and Subcutaneously - in Patients with Social Coverage in Latam

Full Text

Cost Analysis in Implementing Rituximab for non-Hodgkins Lymphoma - Intravenously and Subcutaneously - in Patients with Social Coverage in Latam

Abstract

Authors

L Renati L Najun Dubos

Back to Volume 18, Issue 7

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now